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Abstract
Cystic fibrosis (CF) is an inherited disorder that affects over 30,000 people in the
US and more than 70,000 people worldwide. Recurring bacterial infections in CF patients
result in tissue damage that dramatically lowers respiratory function and are ultimately
fatal. The formation of bacterial biofilms in the mucus and on lung epithelial tissue
allows pathogens to be protected from antibiotics and the host immune system, making
treatment of infection difficult. The interactions between CF pathogens in co-culture
biofilms are not well understood and were examined in this study. Staphylococcus aureus
and Burkholderia cenocepacia, two common CF pathogens, were used to examine the
effects of co-culture on biofilm formation. We found that S. aureus biofilm formation and
maintenance is inhibited when grown in co-culture with B. cenocepacia. In fact,
supernatant from 3-day-old biofilms of B. cenocepacia was sufficient to reduce S. aureus
biofilms, suggesting that a secreted compound may be responsible for this antagonism.
The results of this study can be used to better understand the complex microenvironments
bacteria experience in CF lungs. Further exploration of this interaction could lead to
discovery of a novel therapeutic or a target for treatment of persistent S. aureus infection.

Introduction
Cystic Fibrosis
Cystic fibrosis (CF) is a recessive genetic disorder most common to Caucasians, a
population in America in which 1 out of every 29 individuals is a carrier for a CF allele
[1]. This disease is inherited by obtaining two copies of a mutant CFTR gene, which
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normally encodes an ion channel in the cell membrane called the cystic fibrosis
transmembrane conductance regulator (CFTR). Both chloride and bicarbonate ions have
been shown to utilize this protein to exit the cell, and they contribute to the maintenance
of salt balance and mucin dissolution for healthy exocrine mucosal secretions [2].
Many different CFTR mutations can lead to a mutant phenotype [3], which can
consist of either the absence or dysfunction of the CFTR channel. Due to CFTR defects,
CF patients have a lowered ability or incapacity to transport chloride and bicarbonate
anions outside of the cell [4]. The resulting ion imbalance causes dehydration of the
mucus outside of the cell, hindering mucociliary clearance and making clearance through
coughing arduous [5]. The altered mucus can affect the antimicrobial function of
defensins, lysozymes, and other host pathogen-targeting compounds [5-7]. The mucus
inside the lumen is rich in carbon and other nutrients, which can be metabolized by
microbes [8]. Thus, the environment in the lumen of the CF lung is conducive to bacterial
growth and infection.
Mutations in the CFTR gene can also result in compromised cellular and immune
function. CF lungs are in a hyper-inflammatory state due to chronic bacterial infections as
well as the accumulation of misfolded and degraded proteins inside the cell. The cellular
process of autophagy normally assists in removal of unwanted proteins and cytosolic
debris through fusion of phagosomes with degradative lysosomes [9]. Defects in
autophagy have been observed in CF-derived cell lines and have been shown to lead to
increased inflammation in the lung airways [10-12]. Furthermore, airway epithelial cells
and neutrophils lacking functional CFTR proteins have altered cytokine responses
compared to wild-type cells [13-15], suggesting a possible impairment of immune
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responses to pathogens.
Due to the viscosity of CF mucus, epithelial cilia are weighed down and clearance
of microbes is severely impeded [16]. This stagnant environment can result in microbial
growth in the mucus and allow bacteria to anchor to lung tissue. Bacteria in this
environment can form biofilms, which are mats of bacterial cells embedded in an
extracellular polymeric substance (EPS) made of polysaccharides, proteins, and
extracellular DNA. EPS forms a sticky matrix that protects the enclosed bacteria from
antibiotics, desiccation, and predation by immune cells.
The ability of bacteria in biofilms to evade the immune system and resist even the
strongest antibiotics contributes to chronic bacterial infections and other symptoms seen
in CF patients [17, 18]. Neutrophil and macrophage invasion to the site of infection leads
to inflammation, which can chronically damage host cells and lead to tissue damage [19].
There is a decrease in surface area for oxygen exchange in the scar tissue that develops
from chronic inflammation [20]. Chronic infection and accumulating tissue damage over
the course of their lives cause CF patients to experience a slow suffocation until the
severity of lung damage leads to death.
Even though the airway in CF patients is rife with nutrients, only some
opportunistic bacterial pathogens succeed in this environment. The most common
pathogens in CF patients are Staphylococcus aureus, Pseudomonas aeruginosa,
Haemophilus influenzae, Stenotrophomonas maltophilia, and members of the
Burkholderia cepacia complex, including Burkholderia cenocepacia [21]. Of these, S.
aureus and P. aeruginosa are the dominant pathogens and can be annually cultured from
80% of CF patients. Infections by these organisms are difficult to treat due to intrinsic
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antibiotic resistance. In addition, these pathogens are frequently spread between patients
nosocomially [22, 23]. Development of new therapeutics against these bacteria could
benefit both CF patients and hospitalized individuals worldwide.

Staphylococcus aureus
S. aureus is a Gram-positive, non-motile bacterial species first discovered in 1880
in a skin abscess by Sir Alexander Ogsten [24]. It is estimated that 30% of the human
population carry S. aureus as a commensal organism [25], usually in the upper
respiratory tract, and it can be found commensally on other mammals [26-34]. The
genome of S. aureus consists of a single 2.8 megabase pair (Mbp or 1 million base pairs)
chromosome and contains pathogenicity islands for a variety of toxins and other
virulence factors [34]. Plasmids and several other mobile genetic elements encode
antibiotic resistance genes in both methicillin sensitive (MSSA) and methicillin resistant
(MRSA) S. aureus strains.
As an opportunistic pathogen, S. aureus can cause a variety of infections in
susceptible hosts. This species is the most frequent infectious agent of infective
endocarditis [35] and osteoarticular infection [36]. This species can cause pneumonia
[37], infection of prosthetic joints [38-39], and it can form biofilms on catheters [40],
prosthetic heart valves [41], pacemakers [42] and other prosthetic devices [43]. Skin and
soft tissue infections by S. aureus manifest as abscesses, cellulitis, boils, impetigo, and
infection of wounds [44].
As a primarily extracellular pathogen, the Microbial Surface Components
Recognizing Adhesive Matrix Molecules (MSCRAMM) are a critical component of S.
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aureus pathogenicity and contribute to the initial attachment to host cells [53,54]. These
proteins are located on the surface of the cell, covalently bound to the peptidoglycan of
the cell wall [55]. Components of S. aureus MSCRAMM include fibronectin binding
proteins, clumping factors, and S. aureus protein A (SpA) [56-59]. Fibronectin binding
proteins and clumping factors act as adhesins, anchoring the cells to the extracellular
matrix of host tissue for colonization [53]. SpA is a protein unique to S. aureus and
contains several immunoglobulin-binding domains [60]. The function of SpA is to bind
the Fc portion of immunoglobulin G. This interaction prevents Fc from being recognized
by – and interacting with – phagocytic neutrophils and macrophages, thereby allowing S.
aureus to avoid detection by the circulating antibodies and evade classical complement
formation, opsonization, and phagocytosis [61].
The majority of S. aureus strains produce exotoxins that function as
superantigens, which are potent mitogens that trigger massive proliferation of T cells and
cytokine production [45]. This immune response can overwhelm the human body and
lead to septic shock. Enterotoxins secreted by this species and other staphylococci
quickly cause food poisoning when consumed from undercooked, unpasteurized, or
handler contaminated foods [46, 47]. Another S. aureus toxin, called toxic shock
syndrome toxin, is a causative agent of toxic shock syndrome [48].
Other toxins produced by S. aureus strains do not act as superantigens but directly
target host cells for destruction. Leukotoxins produced and secreted by S. aureus act to
form holes in the membrane of host leukocytes, upsetting the osmotic balance and
resulting in cell lysis [49]. The leukotoxin γ-hemolysin targets red blood cells and can
cause massive hemolysis [50], while the monomeric α-toxin (or α-hemolysin) is highly
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cytotoxic and polymerizes to form a water channel in host cell membranes [51]. This
leukotoxin leads to apoptosis through activation of a caspase cascade [52]. These
leukotoxins extend bacterial infection by eliminating predatory immune cells and
enhancing invasion of host tissue.
In addition to producing adhesins for attachment to host tissue during initial
colonization, S. aureus also produces factors that assist in cell-to-cell binding and biofilm
formation. The intercellular adhesin (ica) locus is found in S. aureus and several other
staphylococcal species and encodes enzymes necessary for the production of
polysaccharide intercellular adhesin (PIA), a component of staphylococcal EPS [62]. The
products of the ica locus are necessary for initiation of biofilm formation by assisting in
intercellular attachment between cells. The ability of S. aureus to form biofilm and attach
to biomedical implants contributes to its ability to cause sepsis and recurring infection in
host tissue.
Difficulty in treatment of S. aureus infection is due to the extensive range of
antibiotics to which both MSSA and MRSA strains have evolved resistance. Over 90% of
S. aureus isolates encode β-lactamase, eliminating certain penicillins as useful antibiotics
[63]. While penicillinase-resistant penicillins are available, they are usually limited to
treatment of severe MSSA infection. After its introduction in 1961, strains resistant to
methicillin – a penicillinase-resistant penicillin – quickly surfaced [64], and MRSA
strains have rapidly increased in prevalence of infections over the past 50 years. In the CF
community, MRSA infection has increased from 6.1% of patients in 2000 to 26% in 2015
[21].
The mecA gene in MRSA isolates is located on the staphylococcal cassette
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chromosome mec (SCCmec) and encodes the enzyme that confers resistance to
methicillin, penicillin, and other β-lactams [65]. The SCCmec is a mobile genetic element
capable of horizontal gene transfer between staphylococcal strains [66]. Some studies
suggest vancomycin is inferior to β-lactams as an antimicrobial, but it is still able to
effectively eliminate infection of both MSSA and MRSA [67, 68]. However, strains
bearing vancomycin resistance (VRSA) have also begun to appear in isolates of S. aureus
[69], increasing the vital need for discovery of new anti-staphylococcal compounds and
vaccine development for S. aureus.
S. aureus is typically the first organism that colonizes the CF lung and remains
the most common CF isolate in individuals under 25, with prevalence of S. aureus
colonization peaking between ages 11-15 [63,70]. Rates of MRSA infection during
childhood are substantially higher in the United States than in Europe [70].
Approximately 25% of annual CF cultures are positive for MRSA, while the prevalence
of MRSA in Europe remains about 5%. This indicates that MRSA is a pressing problem
in the U.S. and illustrates the need for the development of new treatments for MSSA and
MRSA infection.

Burkholderia cenocepacia
The Burkholderia cepacia complex (Bcc) consists of 18 related Gram-negative
species that thrive in a diverse array of environmental niches and have a broad array of
metabolic capabilities, including nitrogen fixation [71], pollutant metabolism [72, 73],
antifungal production [74], and plant pathogenesis [75]. These bacteria are typically
found in the soil or water, and this versatility seen in Bcc ecological specialization is
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attributable to their uniquely complex genomes. Most Bcc species have genomes over
twice the size of the Escherichia coli genome [76]. Where as the majority of bacteria
have one circular chromosome, Bcc genomes consist of two or three circular
chromosomes and at least one large plasmid [77]. The CF isolate B. cenocepacia J2315,
for example, has four replicons, with approximate sizes of 3.8 Mbp, 3.2 Mbp, 875
kilobase pairs (kbp) and 92 kbp, which together encode over 7,000 predicted coding
regions.
The first isolation of a Bcc member from a CF patient occurred in the 1970s [78],
and a CF epidemic in the 1980s involving B. cenocepacia increased the significance of
the Bcc as opportunistic human pathogens [79]. Analysis of the B. cenocepacia J2315
genome has implicated the role of horizontal gene transfer of genomic islands in the
development of human virulence factors [77]. Currently, B. cenocepacia and B.
multivorans are the most common Bcc species isolated from CF patients in North
America [80] and Europe [81], respectively.
B. cenocepacia strains found in either the environment or as clinical isolates can
be categorized into four different subgroups [82]. Subgroup IIIA includes B. cenocepacia
J2315 and the ET12 lineage from which it is derived. The ET12 lineage of B.
cenocepacia caused a large epidemic in the CF community in the 1980s and 1990s [83].
This strain was transmitted across the United Kingdom, Canada, and Europe due to
contact between patients. The ET12 epidemic lineage encodes a cable pilus that can assist
in binding to both mucins [84] and host tissue [85], and isolates have been shown to
dominate and replace infections originally caused by B. multivorans [86].
B. cenocepacia J2315 contains genes that confer natural resistance to several
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antibiotics, including β-lactams, aminoglycosides, chloramphenicol, trimethoprimsulfamethoxazole, and gentamicin [77]. This strain also expresses type IV pili that are
involved in motility and cellular adhesion to host tissue. Additionally, these pili have
DNA binding activity [87] suggesting they may play a role in biofilm formation, in which
extracellular DNA is a critical component of the secreted matrix. Like S. aureus, the
ability of this strain to bind to both host tissue and form biofilms contributes to its
virulence as a CF pathogen.
The secretion systems utilized by B. cenocepacia J2315 play an important role in
the infection of human tissue. When cells of this strain are taken up by macrophages, the
bacteria evade degradation and survive inside an endocytic vacuole [88]. The type IV
secretion system has been implicated in the ability of B. cenocepacia to survive
macrophage phagocytosis by evasion of lysosomal fusion [89]. The type VI secretion
system has been shown to reduce production of reactive oxygen species inside
macrophages [90].
The importance of Bcc as CF pathogens lie in their high transmissibility between
patients and the quick progression of CF pathogenesis associated with Bcc infection [91].
“Cepacia syndrome” is characterized by bacteremia and a sudden rapid deterioration of
lung function from necrotizing pneumonia [92]. The large majority of incidents of these
symptoms occurred when CF patients were infected with a Bcc member. In addition,
presence of Bcc is correlated with an increased risk of death in CF patients. Even with the
dominance of S. aureus and P. aeruginosa as the most common CF pathogens, the risks
of Bcc infection make exploration of their virulence necessary for the CF community.
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Bacterial Biofilms
Bacteria form biofilms as a defensive mechanism against a variety of potentially
damaging conditions, such as presence of phagocytic predator cells, abrasive mechanical
stimuli, or exposure to antibiotics. Initiation of biofilm formation involves quorum
sensing, which is a method of altering gene expression at the population level based on
cell density [93]. Initially, cells use adhesins and extracellular structures to reversibly
attach to a surface, such as host tissue or synthetic material. During the second stage of
biofilm formation, cells begin secreting molecules for formation of the EPS, which
results in the irreversible attachment of bacteria to other cells and surfaces.
After permanent attachment to a surface, biofilm cells will begin to replicate,
resulting in formation of clusters of bacteria termed microcolonies. Replication and EPS
production continue until a mature biofilm with a unique three-dimensional structure is
formed. Depending on how bacteria are communicating within or between species,
different biofilm morphologies can be observed. P. aeruginosa, one of the most wellstudied biofilm formers, typically forms globular biofilms that resemble mushrooms [94].
This mushroom model of biofilm morphology is a commonly observed phenotype [95].
After biofilm maturation, the final stage of biofilm formation is the release of
cells back to a planktonic, free-swimming lifestyle. This change involves dissolution of a
portion of the biofilm EPS to allow cells to leave the biofilm and potentially begin the
cycle all over again, initiating biofilm formation on another surface [96]. The biofilm
lifestyle can increase the minimum inhibitory concentration of antibiotics 1000-fold
[97,98] and make phagocytosis by macrophages difficult [99, 100], thus increasing the
virulence and persistence of human bacterial pathogens inside the host.
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Co-Culture Biofilms
Single and polymicrobial biofilms can take on unique structures and spatial
organizations that result in complex microenvironments [101, 102]. Different species can
lay down in layers like stacks of paper, can arrange in a heterogeneous mixture of
bacteria and involve contact with other species, or can remain in localized clusters with
little to no cell-to-cell contact between microcolonies. Bacteria at the surface of a biofilm
or in the lining of water channels will have different nutrient and oxygen availability than
those near the bottom or the center of the biofilm. This arrangement results in unique
metabolic states and requirements based on an organism’s location within the biofilm.
Co-infection by pathogens in CF lungs is a common occurrence. In one group of
CF patients participating in a clinical trial, 43.2% of individuals that were colonized by P.
aeruginosa were also colonized by S. aureus [103]. Of 595 patients sampled, an average
of 2.9 strains were cultured per person, including isolates of the biofilm-forming bacteria
P. aeruginosa [104], Achromobacter xylosoxidans [105], B. cepacia [106], S. aureus
[107], and S. maltophilia [108]. Given co-infection of CF patients with these bacteria, the
CF lung likely acts as an ideal environment for the formation of mixed species biofilms,
and the combinations of different strains may result in unique symptoms and severity of
disease.
It is clear that a complex polymicrobial community inhabits CF lungs and that the
microbial contents of CF airways change throughout a patient’s lifetime. Multispecies
biofilms and CF pathogen interactions are therefore important areas of research to
understand CF pathogenesis. Monospecies biofilms have been studied in depth, such as
those of P. aeruginosa [93, 109, 110], but only a few studies have explored co-culture
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biofilms of CF pathogens. For example, the co-culture biofilm of P. aeruginosa and S.
maltophilia may act to enhance antibiotic resistance compared to single species biofilms
[111]. Clinical isolates of B. cepacia and P. aeruginosa grown in co-culture have been
shown to form stable mixed biofilms [112]. In another study, P. aeruginosa PAO1
enhanced biofilm formation in S. aureus when grown in co-culture [113]. These studies
are preliminary, and the interactions between many different CF pathogens remain to be
explored. Currently, there is little to no understanding of the interaction between S.
aureus and B. cenocepacia in a multispecies biofilm. The prevalence of the former and
the mortality of the later make interactions between the pair an interesting topic of study.
The purpose of this study was to analyze polymicrobial interactions and biofilm
formation in co-culture conditions of different CF pathogens. Originally, representative
strains of five CF pathogens commonly isolated from the CF lung were tested for coculture biofilm formation. These pathogens included P. aeruginosa, S. aureus, B.
cenocepacia, A. xylosoxidans, and S. maltophilia. Pairwise combinations of these species
were grown in co-culture conditions and analyzed for biofilm formation, and the unique
interaction between S. aureus and B. cenocepacia was chosen for further exploration. The
data suggests that B. cenocepacia inhibits biofilm formation and maintenance of S.
aureus. Based on these preliminary data, the main hypotheses for this study were that (1)
S. aureus biofilm formation would be inhibited when grown in co-culture with B.
cenocepacia J2315, (2) mature monoculter S. aureus biofilm would be diminished when
exposed to B. cenocepacia, and (3) destruction of S. aureus biofilm in the presence of B.
cenocepacia would occur over time.
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Materials and Methods
Bacterial Isolates and Materials
Luria Broth Lennox formulation (LB) was used to make both agar plates and
liquid culture medium. Unless specified otherwise, all bacterial strains were plated from
freezer stocks on LB agar plates and grown at 37C for 24-48 h. For overnight cultures,
single colonies were inoculated into 5 mL LB and incubated at 37C with aeration until
the next day. Plates and broth were supplemented with antibiotics as indicated. All strains
can be found in the Yoder-Himes Lab strain collection. A complete list of all bacterial
isolates used during the course of this project are listed and described in Table 1.

Table 1. Strains used in this study.
Strain

Description

Antibiotic
Selection

YoderHimes Lab
Strain

Source

B. cenocepacia
J2315

CF clinical isolate

-

Bcc isolates
A1-4

Dr. James Tiedje
(Michigan State
University)

chloramphenicol
100

16-171

This study

chloramphenicol
100

16-172

This study

B. cenocepacia
J2315-301

J2315 bearing plasmid
pIN62 encoding
dsRedExpress
J2315 bearing plasmid
pIN301 encoding GFP

S. aureus NRS77

Blood clinical isolate

-

13-012

S. aureus NRS72

Bacteremia clinical
isolate

-

13-011

S. aureus
AH2183

Derivative of NRS77

-

16-082

chloramphenicol
10

16-081

chloramphenicol
10

16-080

B. cenocepacia
J2315-62

S. aureus
AH3865
S. aureus
AH1710

RN4220* containing a
plasmid encoding
dsRedExpress
RN4220* containing a
plasmid encoding GFP

A. xylosoxidans
AU19284

CF clinical Isolate

-

13-005

S. maltophilia
K279a

Blood clinical isolate

-

HMS Bcc/Pa
3
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BEI Resources; also
known as NCTC 8325
or PS47
BEI Resources; also
known as Sanger476
Dr. Alexander Horswill
(University of Iowa)
Dr. Alexander Horswill
(University of Iowa)
Dr. Alexander Horswill
(University of Iowa)
Dr. John LiPuma
(University of
Michigan)
Dr. Nick Cianciotto
(Northwestern
University)

Dr. Stephen Lory
(Harvard Medical
School)
DH5α containing a
Dr. Annette Vergunst
E. coli DH5α
chloramphenicol
plasmid encoding
16-0103
(University of
pIN62
30
dsRedExpress
Montpelier, France)
DH5α containing a
Dr. Annette Vergunst
E. coli DH5α
chloramphenicol
plasmid pIN301
16-0105
(University of
pIN301
30
encoding GFP
Montpelier, France)
DH5α containing a
Dr. Annette Vergunst
E. coli DH5α
chloramphenicol
plasmid pIN298
16-0106
(University of
pIN298
30
encoding mCherry
Montpelier, France)
*Restriction deficient S. aureus strain RN4220 is defective in the restriction-modification system that
targets foreign DNA for destruction, therefore enhancing genetic manipulation of S. aureus in the lab.
P. aeruginosa
C3719

CF clinical isolate;
small colony variant

-

HMS Bcc/Pa
1
H8-9

Biofilm Quantitation
Choosing Material for Optimized Biofilm Formation
Overnight cultures of S. aureus NRS77, B. cenocepacia J2315, A. xylosoxidans
AU19284, P. aeruginosa C3719, and S. maltophilia K279a in LB were diluted 1:100 in
TSB, and 100 μL of each culture was added to triplicate wells of both a sterilized 96-well
PVC plate (Costar, #29442-384) and a 96-well polystyrene plate (Greiner Bio-One, #655185). The PVC plate was covered with porous sealing film (VWR, #60941-086), and the
polystyrene plate was covered with the provided lid. Both plates were incubated at 37°C
for 24 h. Quantitation of each monoculture biofilm on both plates was completed using
the microtiter dish biofilm formation assay published by O’Toole [114]. Absorbance was
measured using a Tecan Sunrise plate reader with optical density at 595 nm.

Co-culture Biofilm Formation Assays and Optimization
S. aureus NRS77, B. cenocepacia J2315, A. xylosoxidans AU19284, P.
aeruginosa C3719, and S. maltophilia K279a were grown overnight and diluted 1:100 in
Tryptic Soy Broth (TSB). Equal volumes of each strain were added to centrifuge tubes in
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pairs, then vortexed for 5-6 seconds to thoroughly mix the cultures. Two 96-well PVC
plates were sterilized using 70% ethanol and allowed to dry in a biosafety cabinet. To
both plates, 100 μL of mixed co-culture was added to three replicate wells. Positive
controls consisted of triplicate wells with 100 μL of diluted single cultures. Plain TSB
served as a negative control. The plates were sealed using porous sealing film to allow
oxygen to freely cross, then covered with aluminum foil to help prevent desiccation. The
plates were placed in an acrylic tub lined with damp paper towels and incubated at 37C
for 24 or 72 h.

Sonication and Drip Dilutions
Sonication was used to quantitate the number of cells in a biofilm using a
procedure adapted from Harrison, et al [115]. After the 96-well plate had been incubated
for the desired amount of time, the foil and sealing film were removed and the liquid
culture dumped into a 10% (v/v) bleach solution. The plate was gently and briefly placed
upside down on a paper towel to allow residual liquid to be removed from the surface of
the plate. This step helps prevent cross contamination of the wells in the later steps of the
procedure. Aliquots of 115 L of sterile water were added to the wells, and the samples
were incubated for one min. The water was dumped out of the plate and 115 μL of 1%
Tween 20 in LB was added to each well to act as the recovery medium. The plate was
covered with sealing foil (USA Scientific, #2923-0110) and placed on the bottom level of
a test tube rack. The rack was suspended inside an ultrasonic cleaner (Branson 3200)
until the liquid in the wells was submerged below the level of the water in the cleaner.
The plate was subjected to sonication at 60 Hz for 10 min to disrupt biofilms, as
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suggested in the protocol by Harrison, et al [115].
The foil was wiped down with 70% ethanol to ensure it was sterilized. A pipet tip
was use to punch through the foil and transfer 20 μL from the well to 180 μL phosphate
buffer solution (PBS) in row A of a separate flat bottom polystyrene 96-well plate. After
the entire row had been inoculated, 10-fold serial dilutions were performed. Using an
eight-channel pipettor, 10 μL of the entire serial dilution were transferred to a square
plate containing LB medium, which was set on its side and slanted to allow the drops to
run down the agar. The drops were allowed to run three quarters of the way down the
plate before replacing the lid and setting the plate down flat.
Plates were incubated at 37C for 24-48 h, or until colonies became
distinguishable. Supplementary Table 1 shows the colony morphology and incubation
time for each strain. Typically, S. aureus colonies were counted after 24 h, while B.
cenocepacia colonies were counted after 48 h. Colonies were counted in the drip line that
contained between 11-100 colonies for each specific strain, and the number of live
bacteria per milliliter of recovery medium (colony forming units per milliliter or
CFU/mL) was calculated using both these values and the dilution factor of the most
appropriate dilution.

Standardizing Viable Cell Count
To eliminate the variability in the viable cell count of overnight cultures between
strains, drip dilutions were performed for cultures grown to an optical density at 600 nm
(O.D.600) of 0.8, which corresponds to mid-log phase growth. Overnight cultures were
grown by inoculation of 5 mL LB with the desired strain, followed by incubation at 37°C
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with aeration until the next day. Overnight cultures were made for B. cenocepacia J2315,
S. aureus NRS77, S. aureus NRS72, S. aureus AH3865, S. aureus AH2183, S. aureus
AH1710, and S. aureus AH2547. For each strain, 100 L of the overnight culture was
added to fresh, pre-warmed LB. These were allowed to grow at 37C with aeration until
O.D.600 reached 0.8, and the tubes were placed on ice until all strains reached this O.D.
The cultures were serially diluted in PBS, and then drip dilutions were performed to
quantitate the viable cell count of each strain at O.D.600 of 0.8.

Co-Culture Biofilm Assays
Co-culture Biofilms of five CF Pathogens in Pairwise Combinations
The methods described under the sections Co-culture Biofilm Formation Assays
and Optimization and Sonication and Drip Dilutions were followed using all ten pairwise
combinations of B. cenocepacia J2315, S. aureus NRS77, A. xylosoxidans AU19284, P.
aeruginosa C3719, and S. maltophilia K279a. For each combination, equal volumes of
cultures were added to microfuge tubes and vortexed for 5-6 seconds. Triplicate wells of
two 96-well PVC plates received 100 μL of each mixture and plates were incubated for 1
or 3 days. During drip dilutions, only the 103-107 dilutions were plated. Plating of 10 μL
of this serial dilution therefore placed the limit of detection of the viable cell counts at 105
CFU/mL.

The effect of B. cenocepacia J2315 on multiple S. aureus strains
To examine the ability of B. cenocepacia J2315 to affect various S. aureus strains,
four S. aureus isolates were used and paired with B. cenocepacia J2315 in co-culture

20

conditions. Diluted cultures of each S. aureus strain, NRS77, NRS72, AH2183, and
AH3865 were mixed 1:1 (v/v) with diluted B. cenocepacia J2315 culture. In addition to
each co-culture, monocultures were also inoculated in triplicate wells of three different
96-well PVC plates, which were incubated for 1, 3, or 7 days. Wells containing TSB
acted as the negative control. The procedure for the co-culture biofilm formation assay,
with sonication and drip dilutions, was followed for this experiment.

Inoculation of Pre-established S. aureus NRS77 Biofilms with B. cenocepacia J2315
S. aureus NRS77 was grown to an O.D.600 of 0.8, then diluted 1:10 in TSB. In a
sterilized 96-well PVC plate, 100 μL of the culture was added to 10 sets of triplicate
wells. Another set of wells was inoculated with TSB as a negative control. The plate was
sealed with porous film, covered with aluminum foil, and placed in an acrylic bin lined
with damp paper towels. After covering the bin with plastic wrap, the bin was placed in a
37C room for 72 h. Water was added to the bin daily to prevent desiccation of the
biofilms.
The same day that the S. aureus monoculture biofilm plate was to be removed, B.
cenocepacia J2315 and S. aureus NRS77 cultures were grown to an O.D.600 of 0.8 then
diluted 1:100 or 1:10 in TSB, respectively, in a microfuge tube. Based on the results from
the Standardizing Viable Cell Count experiment in the section above, the dilutions of
both strains had approximately the same cell count. Three different cultures were then
made from these dilutions: B. cenocepacia J2315 monoculture, S. aureus NRS77
monoculture, and co-culture of B. cenocepacia J2315 and S. aureus NRS77. In addition
to equalizing the cell count between strains, the total cell count of each strain must be the
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same in the co-culture condition as in the single culture condition. This feat was
accomplished by aliquoting 1 mL of diluted B. cenocepacia J2315 culture into a
microfuge tube, centrifugation of the cells for one min at 21,130 x g, pouring off the
supernatant, then resuspending the pellet in 1 mL of the diluted S. aureus NRS77 culture.
All microfuge tubes were vortexed for 6 seconds to homogenize the mixtures.
The covers from the established S. aureus biofilms were removed and the biofilm
supernatant was poured into a bleach solution. After dabbing off excess liquid from the
surface of the plate, 100 μL of diluted S. aureus NRS77 was added to three sets of
triplicate wells, one set each for day 1, 3 and 7. This step was repeated for the culture of
diluted B. cenocepacia and the co-culture mixture. In addition, 100 μL of diluted B.
cenocepacia was added to three triplicate non-biofilm containing wells to act as a
positive control for biofilm formation at the point of inoculation. TSB was used as a
negative control.
At this point, 9 sets of the triplicate S. aureus NRS77 biofilm wells were
inoculated with either experimental or control treatments. The tenth set of S. aureus
biofilm wells and the negative control from initial S. aureus inoculation were washed
with 115 μL sterile water then scraped into 115 μL of 1% Tween 20 recovery medium
using a P200 pipette tip. The medium was pipetted out of the wells, serially diluted, and
plated for drip dilutions to determine the starting CFU/mL of the S. aureus biofilm at the
point of B. cenocepacia inoculation.
The biofilms were once again covered with porous sealing film and aluminum
foil, and then placed on damp paper towels in an acrylic, plastic-wrap-covered bin. The
plate was incubated for 1, 3, and 7 days. On each day, the plate was uncovered, the liquid
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culture of the wells of interest were removed with a pipette, and the wells were washed
with sterile water, as described above. Because wells containing conditions for 1, 3, and 7
day biofilm formation were all on the same plate, biofilms were disrupted by scraping
with a 200 μL pipette tip, instead of through sonication. Biofilms were quantitated using
drip dilutions. The plate was covered and incubated at 37C between time points. On the
final day, the negative control was also plated.

Fractionating B. cenocepacia J2315 cultures
B. cenocepacia J2315 cultures were separated into the supernatant and cellular
components. Supernatant was isolated in two ways. First, B. cenocepacia J2315 was
grown in a biofilm for three days in 64 wells of a 96-well PVC plate, as described above
for the growth of monoculture S. aureus biofilm. On day three, the liquid from each well
was removed and added to a microfuge tube. The cells were pelleted at 21,130 x g in a
microfuge for one min, and the supernatant was filter-sterilized through a 0.45 m
syringe filter. Aliquots of this sterilized supernatant were plated to ensure no viable B.
cenocepacia J2315 cells remained.

The total volume of collected supernatant was

approximately 6.4 mL. To this, 6.4 mL of 20% glycerol in LB was added to result in a
10% glycerol solution that could be stored at -20°C until use.
Overnight culture supernatant was also isolated. B. cenocepacia J2315 was grown
overnight in LB, centrifuged at 21,130 x g for one min, and the supernatant was filtersterilized. Each supernatant solution was added 1:1 (v/v) with TSB and added to S.
aureus biofilm to yield a 25% biofilm supernatant treatment and a 50% overnight
supernatant treatment, both with 50% TSB. Additionally, the pellet formed after the
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centrifugation of the overnight B. cenocepacia J2315 culture was resuspended and diluted
1:100 in TSB before addition to S. aureus biofilms.

Sonication of B. cenocepacia J2315 cells and biofilm assay
To determine if live cells were needed for the toxic effect on S. aureus, dead B.
cenocepacia cells were made by placing an overnight culture of the J2315 strain in a
65°C water bath for 30 min then sonicated at 60% amplitude for 10 second pulses over a
period of 10 min in a Qsonica cup sonicator (Qsonica, Q800R). This culture was not
diluted, but mixed with TSB in a 1:1 (v/v) ratio. Plating of serial dilutions of the resulting
culture showed no viable cells remained after sonication.
Live cells, sonicated cells, or either supernatants were added to triplicate wells
containing one-day old S. aureus biofilms and also to empty wells to act as controls. One
set of triplicate wells containing S. aureus biofilm received 100 μL plain TSB to act as a
control for S. aureus biofilm formation. Another set of empty wells received TSB as a
negative control. Two PVC plates were made with these conditions, and one was
incubated at 37C for 24 h, while the second was incubated for 72 h. The protocol
described above in Sonication and Drip Dilution Biofilm was used to quantitate biofilm
formation.

Phenotypes of Co-culture Biofilms
Super Optimal Broth Preparation for B. cenocepacia Transformation
Super optimal broth (SOB) and super optimal broth with catabolite repression
(SOC) are media used to promote higher plasmid transformation efficiency in bacteria.
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To make SOB, 20 g tryptone, 5 g yeast extract, and 0.5 g NaCl were added to 950 mL
sterile water and shaken until dissolved. To this solution, 10 mL of 250 mM KCl was
added and the pH adjusted to 7.0. After autoclaving for 20 min, the medium was placed
in a 55°C water bath to cool for about 30 min. Gentamicin (10 μg/mL) was added to the
medium to prevent contamination, as suggested by published protocol for transformation
of B. cenocepacia J2315 [116]. Right before the medium was used, 10 mL of sterile 1 M
MgSO4 and 5 mL 2 M MgCl2 were added. SOC broth was made by adding 20 mL of a 1
M glucose solution to 1 L SOB.

B. cenocepacia Electrocompetent Cells
To create electrocompetent cells for transformations, an overnight culture of B.
cenocepacia J2315 was grown in 5 mL SOB medium. The next day, the culture was
diluted into an Erlenmeyer flask containing 50 mL SOB to make a final O.D.600 of 0.01.
The flask was incubated with aeration at 37C for 2-3 generations, until the O.D.600 was
between 0.04-0.08 based on the published protocol [116]. This equates to about 4-6 h of
incubation. Next, the flask was chilled on ice for 5 min to stop bacterial growth, and the
culture was aliquoted and centrifuged at 5000 x g for 8 min at 4°C (Kendro Lab Products,
Sorvall Legend RT Centrifuge). The supernatant was removed, and the pellet was washed
and resuspended in 20 mL ice-cold sterile 0.5 M sucrose, followed by two additional
rounds of centrifugation, washing, and resuspension. The final pellet was resuspended in
0.5 mL 0.5 M sucrose. An LB and glycerol solution was added to make the final
concentration 10% glycerol. The sample was divided into 500 μL aliquots and stored at
-80°C until electroporation.
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Transformation of B. cenocepacia J2315
Following the QIAprep Spin Miniprep Kit (Qiagen, #27106) protocol, plasmids
encoding fluorescent proteins were purified from the E. coli DH5α strains provided by
Dr. Annette Vergunst (University of Montpelier, France). These are listed in Table 2. The
purity and DNA concentration for each purified plasmid was determined using a
Nanodrop 2000 (Thermo Fisher Scientific). Plasmids were stored at -20C until use.
The plasmids, thawed electrocompetent B. cenocepacia cells, and electroporation
cuvettes (VWR, #89047-206) were kept on ice. To 15 μL water, 0.1 g of each plasmid
was added, followed by the addition of 55 μL of electrocompetent B. cenocepacia. The
negative control consisted of electrocompetent cells without the addition of plasmid.
After transferring this volume to a 2 mm electroporation cuvette, cells were
electroporated at 2.5 kV (Bio-Rad Micropulser). Samples were removed from the cuvette
by adding 950 μL SOC medium, and after gentle mixing, the volume was transferred to a
microfuge tube. Samples were incubated at 37C, without aeration, for 4-5 h and plated
on LB plates supplemented with 100 μg/mL chloramphenicol. Plates were incubated for
three days. Single colonies were plated in patches on selective plates, and the resulting
growth was observed under a confocal microscope to confirm fluorescence. Colonies that
showed the proper fluorescence profile were stored in 20% glycerol at -80°C under the
strain list designations shown in Table 1.

Confocal Laser Scanning Microscopy Preparation and Analysis
To capture images of both single and co-culture biofilms, the fluorescent strains S.
aureus AH1710 and B. cenocepacia J2315-62 were utilized. Each strain was individually
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inoculated in test tubes containing 5 mL LB supplemented with 10 g/ml or 100 g/ml
chloramphenicol, respectively. Cultures were incubated at 37C overnight then diluted
1:100 in TSB supplemented with 10 μg/mL chloramphenicol. Glass bottom FluoroDishes
(World Precision Instruments, FD35-100) were used to grow the biofilms. Three sets of
triplicate dishes were made for each monoculture and co-culture conditions. Dishes
contained 3 mL of S. aureus AH1710, 3 mL of B. cenocepacia J2315-62, or 3 mL of a
1:1 by volume mixture of the two. Confocal laser scanning microscopy (CLSM) analysis
occurred at 1 day, 3 days, and 7 days post-inoculation of each condition. At each time
point, the biofilm supernatant was discarded prior to microscopy. Both 2D and 3D
imaging was captured using NIS-Element software with both the 40x and 60x lenses of a
Nikon Eclipse Ti microscope. The GFP (487 nm) and TxRed (561 nm) lasers were used
for excitation wavelengths. The power and gain of each image was optimized to show
maximum fluorescence without saturation of the image.

Statistical analyses
All biofilm assays and viable cell count assays were graphed and analyzed using
GraphPad Prism v. 5.1.0. Statistical significance was calculated using either two-way
ANOVA analysis, one-way ANOVA analysis in conjunction with Tukey’s multiple
comparison test, or an unpaired T test, as indicated in each figure legend. Only p-values
less than 0.05 were considered statistically significant.
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Results
Choosing Material for Optimized Biofilm Formation
In order to test for the plate material that optimizes biofilm formation,
representative strains of five common CF pathogens were chosen to form monoculture
biofilms in 96 well plates made of two different materials. Twenty-four hour monoculture
biofilms of S. aureus NRS77, B. cenocepacia J2315, A. xylosoxidans AU19284, P.
aeruginosa C3719, and S. maltophilia K279a were grown in both round-bottom 96-well
PVC plates and flat-bottom 96-well polystyrene plates. Biofilm was quantitated using the
retention of crystal violet as described in the Materials and Methods. Results are shown
in Figure 1.

Figure 1. Biofilm formation in polystyrene and PVC 96-well plates. The optical density of
biofilm growth was obtained for one-day-old monocultures of A. xylosoxidans AU19284 (red), P.
aeruginosa C3719 (orange), S. maltophilia K279a (green), S. aureus NRS77 (blue), and B.
cenocepacia J2315 (purple) grown in both PVC and polystyrene 96-well plates. Two-way
ANOVA analysis showed an overall significant effect of the interaction between strain type and
plate material (p < 0.0001). Unpaired t-tests were used to calculate significance between strains
grown on each plate material (*p < 0.05, ****p < 0.0001).
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Unpaired t-tests of each strain showed that for all strains except S. maltophilia
K279a, biofilm formation was significantly greater in 96-well PVC plates compared to
polystyrene 96-well plates (Fig. 1).

S. maltophilia K279a grew optimally in the

polystyrene 96-well plate but was still able to form biofilm that was comparable to the
biofilm formation of the other four isolates in the 96-well PVC plate. Due to these
observations, the 96-well PVC plate was chosen to use in all future biofilm formation
assays.
Co-culture Biofilms of Five CF Pathogens in Pairwise Combinations
After establishing that round-bottom, 96-well PVC plates were conducive for
biofilm formation for a majority of the strains (Fig. 1), the same five isolates were tested
for compatibility of biofilm formation in co-culture conditions. All pairwise
combinations of B. cenocepacia J2315, S. aureus NRS77, A. xylosoxidans AU19284, P.
aeruginosa C3719, and S. maltophilia K279a were inoculated in triplicate wells of a 96well PVC plate and incubated for 1 or 3 days. Biofilm quantitation was completed using
sonication and drip dilutions, and viable cell counts for each strain in co-culture were
compared to each strain in monoculture.
Supplementary Figure 1 shows the data and summarizes the results for
monoculture and co-culture biofilm formation of A. xylosoxidans AU19284, P.
aeruginosa C3719, and S. maltophilia K279a. The data for B. cenocepacia J2315 and S.
aureus NRS77 (Fig. 2) suggested that the presence of S. aureus NRS77 has no effect on
B. cenocepacia J2315 biofilm formation, but the presence of B. cenocepacia J2315
results in a reduction in viable cells below the limit of detection for S. aureus NRS77
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biofilm by day 3. These results suggested that the presence of B. cenocepacia J2315 may
inhibit S. aureus NRS77 biofilm formation over time.

Figure 2. Biofilm formation of B. cenocepacia J2315 and S. aureus NRS77 in co-culture
conditions. Viable cell counts of (A) S. aureus NRS77 biofilms and (B) B. cenocepacia J2315
biofilms when grown in co-culture with A. xylosoxidans (red), P. aeruginosa C3719 (orange), S.
maltophilia K279a (green), S. aureus NRS77 (blue), or B. cenocepacia J2315 (purple). Presence
of an “X” indicates exclusion of data due to contamination of samples. Absence of a bar indicates
the viable counts are below the limit of detection (gray line), which was 105 for this experiment.
One-way ANOVA analysis showed an overall significant difference among means (p < 0.05) in
CFU/mL within both S. aureus NRS77 and B. cenocepacia J2315 data. Tukey’s multiple
comparison test was used to compare co-culture and monoculture conditions (*p < 0.05).

Effect of B. cenocepacia J2315 on S. aureus Strains
Next, the ability of B. cenocepacia J2315 to inhibit biofilm formation in other S.
aureus strains was tested. It was hypothesized that inhibition of S. aureus biofilm by B.
cenocepacia J2315 would not be limited to the NRS77 strain. Mixes of B. cenocepacia
J2315 and four S. aureus strains – NRS77, NRS72, AH2183, and AH3865 – were made
and inoculated in a 96-well PVC plate and allowed to incubate for 1, 3, or 7 days before
the co-culture biofilms were quantitated by sonication and drip dilutions. The viable cell
count was then compared to viable counts from monoculture biofilms.
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There was no statistical significance in biofilm formation of B. cenocepacia J2315
between S. aureus strains or over time (Fig. 3), while all tested S. aureus strains were
inhibited over time by the presence of B. cenocepacia J2315 (Fig. 4). Viable S. aureus
NRS77 biofilm was below the limit of detection (103 CFU/mL) in the presence of B.
cenocepacia J2315 (Fig. 4A). Biofilms of S. aureus NRS72 were present after growing
for 1 day with B. cenocepacia J2315, but growth was significantly inhibited in
comparison to the monoculture biofilm, and by day 3, viable S. aureus NRS72 biofilm
was reduced beyond the limit of detection in co-culture with B. cenocepacia J2315 (Fig.
4B).

Figure 3. Effect of S. aureus strains on B. cenocepacia J2315 survival in co-culture biofilms.
B. cenocepacia J2315 was mixed with S. aureus strains NRS77, NRS72, AH3862, or AH2183 for
1, 3, or 7 days. Biofilm formation was quantitated using sonication and drip dilutions, and biofilm
viable cell counts were compared to monoculture biofilm growth of B. cenocepacia J2315. Oneway ANOVA with Tukey’s multiple comparison test showed no significant difference over time
or between co-culture conditions.

S. aureus AH3865 was able to form biofilm as effectively in the presence of B.
cenocepacia J2315 as in monoculture during day 1, but was significantly inhibited by day
3 (Fig. 4C). S. aureus AH2183 biofilm formation appeared to be inhibited in the presence
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of B. cenocepacia J2315 after 1 day, but this effect was not statistically significant (Fig.
4D). On day 3, however, the decrease in S. aureus AH2183 co-culture biofilm was
statistically significant in comparison to monoculture. All strains of S. aureus had no
detectable biofilm on day 7 in the presence of B. cenocepacia J2315. This data suggests
that B. cenocepacia J2315 inhibits biofilm formation in multiple S. aureus strains.

Figure 4. Effect of B. cenocepacia J2315 on multiple S. aureus strains during biofilm
formation over time. S. aureus strains NRS77 (A), NRS72 (B), AH3865 (C), and AH2183 (D)
were grown in monoculture and in co-culture with B. cenocepacia J2315 for 1, 3, or 7 days.
Biofilm formation was quantitated using sonication and drip dilutions. Bars representing biofilm
formation of S. aureus strains grown alone (blue) or grown in co-culture with B. cenocepacia
J2315 (purple striped) are shown. Limit of detection is indicated by the gray line. Unpaired t-test
measured significant differences as indicated by brackets and asterisks (*p < 0.05, **p < 0.01,
****p < 0.0001).
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Standardizing the Viable Cell Count of Isolates with O.D.600
In the previous experiments, an equal volume of each overnight culture was used
when inoculating 96-well plates for co-culture biofilm formation. However, because S.
aureus is a coccus and B. cenocepacia is a bacillus, the size difference between species
may result in a different concentration of cells per unit volume of medium. Additionally,
the viable cell count of overnight cultures within one strain may not be consistent
between replicates. We sought to eliminate the difference in cell number between B.
cenocepacia J2315 and S. aureus NRS77 as a possible source of variation.

Figure 5. Viable cell count of isolates with O.D.600 of 0.8. Overnight cultures were diluted in
fresh LB and grown to O.D.600 of 0.8, serial diluted, and plated. Viable cell counts were collected
for B. cenocepacia J2315, and the indicated S. aureus. One-way ANOVA analysis showed no
significant differences between strains.
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Performing drip dilutions on cultures with an O.D.600 of 0.8 standardizes the
viable cell count of each strain. This process was completed for B. cenocepacia J2315
and for S. aureus strains NRS77, AH3865, AH2183, AH1710, and AH2547. Results
show that all S. aureus strains had an average concentration of approximately 108
CFU/mL at this O.D.600 reading, while B. cenocepacia J2315 had an average
concentration around 109 CFU/mL (Fig. 5). Therefore, when creating 50/50 mixes of B.
cenocepacia J2315 and any of the aforementioned S. aureus strains grown to O.D.600 of
0.08, B. cenocepacia J2315 may have 10-fold the number of cells compared to S. aureus.
This led to a fundamental change in our experimental design. In the following
experiments, after strains reached an O.D.600 of 0.8, B. cenocepacia J2315 was diluted
10-fold in comparison to S. aureus NRS77 to account for differences in cell size.

Effect of B. cenocepacia J2315 on Pre-Established S. aureus NRS77 Biofilms
The results from the above experiments show that the J2315 strain of B.
cenocepacia is able to prevent S. aureus from forming and maintaining the biofilm
lifestyle. We sought to determine if B. cenocepacia J2315 is also able to destroy mature
S. aureus NRS77 biofilms. We hypothesized that mature S. aureus biofilms would be
able to survive inoculation of B. cenocepacia J2315, but biofilm viable cell counts would
show a progressive decrease over time, while B. cenocepacia J2315 biofilms would be
unaffected.
S. aureus biofilms were formed for 3 days before the addition of either more S.
aureus NRS77, a 50/50 mixture of S. aureus NRS77 and B. cenocepacia J2315, or B.
cenocepacia J2315. After 1 day, there was no significant difference between S. aureus
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biofilms of any treatment (Fig. 6). On day 3, there was a significant decrease in S. aureus
NRS77 biofilm in both the treatment with B. cenocepacia J2315 / S. aureus NRS77
mixture and the treatment with B. cenocepacia J2315. Only the treatment with B.
cenocepacia J2315 showed a statistically significant decrease in S. aureus NRS77 biofilm
formation on day 7. In addition, compared to monoculture conditions, there was no
statistically significant difference in B. cenocepacia J2315 biofilm formation in the
presence of S. aureus NRS77 biofilms (data not shown).

Figure 6. Inhibition of mature S. aureus NRS77 biofilms by B. cenocepacia J2315. Mature, 3day old S. aureus NRS77 biofilms were inoculated with S. aureus NRS77 (blue), a 50:50 mixture
of S. aureus NRS77 and B. cenocepacia J2315 cultures (purple striped), or B. cenocepacia J2315
(blue bar, purple outline) and grown for 1, 3, and 7 days. Biofilms were quantitated for each
condition using sonication and drip dilutions. Limit of detection is indicated by a gray line. Oneway ANOVA with Tukey’s multiple comparison tests analyzed significant differences of biofilm
formation between treatments (*p < 0.05, **p < 0.01 ***p < 0.001).
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Together, these data continue to support the hypothesis that B. cenocepacia J2315
is diminishing the ability of S. aureus NRS77 to form or maintain a biofilm state. Not
only does B. cenocepacia J2315 prevent biofilm formation of S. aureus NRS77 upon
simultaneous inoculation, but it also results in the reduction of S. aureus NRS77 biofilm
that has already been established. It is not clear if this inhibition is due to the presence of
planktonic B. cenocepacia J2315, B. cenocepacia J2315 biofilm, or a combination of
both.

Exploring the Mechanism of S. aureus Biofilm Inhibition
This experiment was designed to determine if inhibition of S. aureus biofilm by
B. cenocepacia was through a secreted or shed product, and to determine if live B.
cenocepacia cells are necessary for S. aureus biofilm destruction. Five B. cenocepacia
J2315 treatments for S. aureus biofilms were chosen to answer these mechanistic
questions and are depicted in Table 2. B. cenocepacia J2315 seems to specifically inhibit
biofilm formation in S. aureus and does not appear to reduce biofilm of other tested
species (Supplementary Fig. 1). Due to these observations, it was hypothesized that B.
cenocepacia J2315 needed to recognize the presence of S. aureus NRS77 to mediate
biofilm reduction, and would, therefore, require the presence of live B cenocepacia J2315
cells.
For clarification, the results from this experiment have been separated into four
sections: the effect of sonicated B. cenocepacia J2315 cells, B. cenocepacia J2315
biofilm supernatant, B. cenocepacia J2315 overnight supernatant, and B. cenocepacia
J2315 pelleted planktonic cells on S. aureus NRS77 biofilms. The effects of all B.
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cenocepacia J2315 fractions on S. aureus NRS77 biofilms were compared to
monoculture S. aureus NRS77 biofilm formation. In addition, results could be compared
to the inhibition of S. aureus NRS77 biofilms treated with whole B. cenocepacia J2315
culture. This was the same condition tested in previous experiments and therefore acted
as a positive control for S. aureus NRS77 biofilm inhibition.
Table 2. Experimental design for exploring possible mechanisms of B. cenocepacia
J2315-mediated destruction of S. aureus NRS77 biofilm
Treatment
Source
Purpose or question addressed
Whole B. cenocepacia
J2315

Overnight culture

Positive control for S. aureus NRS77
biofilm inhibition

Sonicated B.
cenocepacia J2315

Overnight culture,
sonicated

(1) Is live B. cenocepacia J2315 necessary
for S. aureus biofilm reduction?

B. cenocepacia J2315
biofilm supernatant

Filter-sterilized
supernatant of a 3-day-old
monoculture biofilm

B. cenocepacia J2315
overnight supernatant

Filter-sterilized
supernatant of an
overnight culture

Pelleted/resuspended
B. cenocepacia

Overnight culture, pelleted
and resuspended in fresh
medium

(1) Do biofilm secretions result in S.
aureus biofilm reduction?
(2) Is cell-to-cell contact necessary for S.
aureus biofilm reduction?
(1) Do planktonic secretions result in S.
aureus biofilm reduction?
(2) Is cell-to-cell contact necessary for S.
aureus biofilm reduction?
(1) Are cells alone sufficient to induce S.
aureus biofilm reduction?
(2) Is cell-to-cell contact necessary for S.
aureus biofilm reduction?

The effect of sonicated B. cenocepacia J2315 cells on S. aureus NRS77 biofilms
B. cenocepacia J2315 was subjected to sonication in order to lyse cells.
Following the sonication treatment, serial and drip dilutions of lysed cells suggested no
detectable levels of viable B. cenocepacia cells remained (data not shown). This
sonicated mixture was mixed with TSB 1:1 (v/v) and added to one-day-old S. aureus
NRS77 biofilm. Biofilms were incubated for 3 days. The resulting data shows that there
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was no significant difference in the viable cell count of the S. aureus NRS77 biofilm and
the S. aureus biofilm exposed to sonicated B. cenocepacia J2315 (Fig. 7). In comparison,
the significant inhibition of the S. aureus NRS77 biofilm due to the B. cenocepacia J2315
control on day three suggests that the process that leads to S. aureus biofilm antagonism
requires live B. cenocepacia J2315.

Figure 7. Effect of B. cenocepacia J2315 components on S. aureus NRS77 biofilm. One-day-old S.
aureus NRS77 biofilm was inoculated with either TSB or one of five experimental treatments. S.
aureus NRS77 biofilm was quantitated after three days using sonication and drip dilutions. One-way
ANOVA analysis showed a significant effect of treatment (p < 0.0001), and Tukey’s multiple
comparison test analyzed for significant difference of treatments in comparison to the treatment with
whole B. cenocepacia J2315 (Red box; *p < 0.05, ***p < 0.001, ****p < 0.0001) and the S. aureus
monoculture condition (Green box; p < 0.05,p < 0.0001). Statistical difference of S. aureus
NRS77 biofilm formation between B. cenocepacia J2315 overnight and biofilm supernatant
treatments is also shown (p < 0.001).

The effect of B. cenocepacia J2315 biofilm supernatant on S. aureus NRS77 biofilms
B. cenocepacia J2315 biofilm was grown for three days, and the supernatant was
collected and filter-sterilized before being mixed with TSB for addition to a one-day-old
S. aureus NRS77 biofilm. After incubation for 3 days, the S. aureus NRS77 biofilm
viable cell count was measured following sonication and drip dilutions. Analysis of the
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resulting data shows exposure to the biofilm supernatant caused a statistically significant
decrease in S. aureus NRS77 biofilms compared to the S. aureus NRS77 monoculture
biofilms. There was no statistically significant difference in S. aureus NRS77 biofilm
inhibition when comparing the exposure to whole B. cenocepacia J2315 to the exposure
to B. cenocepacia J2315 biofilm supernatant.
Both the presence of B. cenocepacia J2315 cells and the exposure to B.
cenocepacia J2315 biofilm supernatant results in a reduction of S. aureus NRS77 biofilm.
This suggests that B. cenocepacia J2315 is secreting or shedding a substance during
biofilm formation that is a potential inhibitor of S. aureus NRS77 biofilms. Additionally,
B. cenocepacia J2315 does not require the presence of S. aureus NRS77 for production of
the inhibiting substance.

The effect of B. cenocepacia J2315 overnight supernatant on S. aureus NRS77 biofilms
The overnight culture of B. cenocepacia J2315 was centrifuged and the
supernatant was collected, filter-sterilized, and stored in a 1:1 mixture of a glycerol
solution for storage until use. On the day of inoculation of one-day-old S. aureus NRS77
biofilm, the supernatant glycerol solution was mixed 1:1 (v/v) with TSB and added to S.
aureus NRS77 biofilms. Quantitative analysis through sonication and drip dilutions was
completed for S. aureus NRS77 biofilms after three days of incubation.
B. cenocepacia J2315 overnight supernatant decreased S. aureus NRS77 biofilm
to a mild but significantly lower level compared to treatment with whole B. cenocepacia
J2315 (Fig. 7). These results suggest that B. cenocepacia J2315 may be able to secrete or
shed a product during growth of overnight culture that results in a slight reduction of S.
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aureus NRS77 biofilms. However, because the effect of the overnight supernatant
treatment did not result in the same level of inhibition as whole cultures, this suggests
that either an inhibitory molecule is not optimally expressed during overnight growth or
that there is an additive effect of B. cenocepacia J2315 cells and supernatant on S. aureus
biofilm inhibition.

The effect of pelleted planktonic cells on S. aureus NRS77 biofilms
An overnight culture of B. cenocepacia J2315 was centrifuged, and the
supernatant was removed. The resulting pellet was resuspended and diluted in fresh TSB
then added to one-day-old S. aureus NRS77 biofilm and incubated for one or three days.
Biofilm was quantitated through sonication and drip dilutions. Statistical analysis showed
that after three days the viable cell count of S. aureus NRS77 biofilms was statistically
lower than the monoculture S. aureus NRS77 biofilms but not statistically different than
the S. aureus NRS77 biofilms exposed to whole B. cenocepacia J2315 (Fig. 7). This
result indicates that B. cenocepacia J2315 cells, both with and without supernatant from
overnight growth, are capable of reducing S. aureus NRS77 biofilm to the same extent.
Altogether, the data presented above suggest that our original hypothesis
regarding a potential mechanism of S. aureus biofilm reduction was likely incorrect. B.
cenocepacia J2315 does not require the presence of S. aureus NRS77 in order to produce
an inhibitory effect on S. aureus NRS77 biofilm viability. It appears as if there is an
antagonistic substance in the supernatant of B. cenocepacia J2315 – both from cells in a
planktonic and biofilm lifestyle – that interacts with S. aureus NRS77 biofilm in a way
that leads to a reduction in the viable cell count of cells in the biofilm.
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Transformation of B. cenocepacia J2315
To better understand the interactions between S. aureus strains and B.
cenocepacia J2315 in biofilms, strains encoding fluorescent proteins were obtained. S.
aureus strains bearing GFP- and dsRedExpress-encoding plasmids (Table 1) were
obtained from Dr. Alexander Horswill at the University of Iowa. To generate fluorescent
B. cenocepacia J2315, a protocol established by Dubarry et al. [116] was followed, and
transformants of B. cenocepacia J2315 expressing GFP (J2315-301), mCherry (not
named) and dsRedExpress (J2315-62) were created. The mCherry transformants showed
weak fluorescence and were quick to photobleach, while both the GFP strain and
dsRedExpress strains showed strong fluorescence that did not fade quickly. The latter
two strains were used in conjunction with the provided S. aureus strains to observe coculture biofilms with confocal laser scanning microscopy, which allows 3-dimensional
biofilm structures to be observed.

Phenotypes of Co-culture Biofilms
To observe the phenotypic and spatial interaction between these organisms,
strains B. cenocepacia J2315-62 (red fluorescence) and S. aureus AH1710 (green
fluorescence) were grown in triplicate in both co-culture and monoculture conditions for
1, 3, or 7 days in glass-bottomed petri dishes. In addition, another set of dishes were
inoculated with S. aureus AH1710 monoculture and incubated for 3 days. The S. aureus
supernatant was then replaced with filter-sterilized supernatant of 3-day-old B.
cenocepacia J2315 biofilm, and the dishes were incubated with the remaining plates. It
was hypothesized that the destruction of S. aureus biofilm formed in co-culture with B.
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cenocepacia J2315-62 would be observable over time. Additionally, because B.
cenocepacia J2315 reduces biofilm in several S. aureus strains, we also predicted that S.
aureus AH1710 biofilm exposed to B. cenocepacia J2315 biofilm supernatant would be
reduced.
First, S. aureus AH1710 and B. cenocepacia J2315-62 form morphologically
different biofilms in monoculture compared to co-culture. Single cultures of S. aureus
AH1710 laid down a biofilm in a flat mat, with little to no clustering morphology (Figs.
8A and B), while S. aureus AH1710 cells in co-cultures with B. cenocepacia can
regularly be seen in both flat mats on the surface of the dish and in mixed species
mushroom structures with B. cenocepacia J2315-62 (Figs. 8E and F). The biofilm formed
by B. cenocepacia J2315-62 in monoculture is highly clustered and porous, resembling
honeycomb (Figs. 8C and D). These structures are less apparent when grown in coculture with S. aureus AH1710, where as B. cenocepacia biofilm phenotype appears to
switch from a porous morphology to a mushroom-like structure that surround
clusters of S. aureus (Figs. 8E and F).
While co-culture experiments using 96-well PVC plates showed an absence of
biofilm of four S. aureus strains by day 7 when inoculated simultaneously with B.
cenocepacia J2315 (Figs. 1 and 2), S. aureus AH1710 is still present in the co-culture
biofilm after the same amount of time in co-culture, albeit to a reduced degree (Fig. 9B).
However, S. aureus AH1710 biofilm exposed to 3-day-old sterile supernatant of B.
cenocepacia J2315 appears markedly decreased in comparison to the co-culture
condition. This difference in S. aureus biofilm reduction can be seen in Figure 9B and C.
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Figure 8. CLSM imaging of single and co-culture biofilms of B. cenocepacia J2315-62 and S.
aureus AH1710 over time. Triplicate glass bottom dishes were inoculated with either single
cultures (A-D) or co-cultures (E and F) of B. cenocepacia J2315-62 and S. aureus AH1710 and
grown for 3 (A, C, and E) and 7 days (B,D, and F). Images were captured using NIS-Elements
software, and settings were optimized for each image.
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Based on these observations, it seems as if the presence of B. cenocepacia cells
may be slowing the progression of S. aureus biofilm destruction that results from B.
cenocepacia J2315 secretions when grown in the glass bottom dishes. Alternatively, the
timing of biofilm inhibition may be variable between cultures grown in PVC 96-well
plates and cultures grown in glass-bottom dishes. A longer time period may be required
to see the same levels of inhibition in the glass bottom dishes that is observed in the 96well PVC plate.

Figure 9. Effect of B. cenocepacia J2315 biofilm supernatant on S. aureus AH1710 biofilm.
(A) Monoculture, 7-day-old S. aureus AH1710 biofilm. (B) A 7-day-old co-culture biofilm image
with the red channel (B. cenocepacia J2315-62) removed, and only the green channel (S. aureus
AH1710) displayed. (C) Three-day-old S. aureus AH1710 biofilm inoculated with 25% B.
cenocepacia J2315 biofilm supernatant in TSB, and incubated for an additional four days.

Although it was shown that both B. cenocepacia J2315 cells and biofilm
supernatant reduce S. aureus biofilm to the same extent (Fig. 7), it is clear that some sort
of alternate interaction is occurring under the conditions of this experiment. The presence
of B. cenocepacia cells still reduces S. aureus biofilm, but appears to slow that reduction
compared to the presence of biofilm supernatant alone. This effect could be due to the
difference in the experimental design between the 96-well plate experiments and the
CLSM experiments. The glass-bottom dishes used for biofilm attachment in this
experiment held a larger volume of inoculated medium compared to the 96-well PVC
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plates used in other experiments. Difference in material or total medium volume may
influence the time it takes for reduction in S. aureus biofilm to occur.
Another possibility is that the substance in the biofilm secretion that results in S.
aureus biofilm destruction is regulated and taken back up by B. cenocepacia. The
presence of B. cenocepacia J2315-62 would decrease the concentration of the biofilmdestroying-substance, thereby slowing S. aureus biofilm degradation in a dose-dependent
manner. This is speculative, and further experimentation needs to be done to identify the
source of S. aureus biofilm-degradation in the B. cenocepacia J2315 biofilm supernatant.

Discussion
Most of the published literature chronicling CF pathogenesis focus on single
culture biofilms of pathogens either in vitro or in vivo; however, co-culture biofilms are
common in nature and in human hosts during the course of disease and thus warrant
further study. Multiple strains and species are commonly cultured from CF lungs [103],
and the unique interactions that may occur in the biofilms of these isolates could provide
key insight into the varying pathogenicity of the disease. The analysis of co-culture
biofilm formation of B. cenocepacia and S. aureus explored in this study has shown a
novel interaction with important implications.
In this study, we found that B. cenocepacia J2315 secretions result in the
degradation of S. aureus biofilm and prevent S. aureus biofilm formation in several
strains. Even when given the opportunity to form mature biofilms, B. cenocepacia J2315
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degrades S. aureus biofilm over time. In contrast, the presence of S. aureus NRS77 does
not seem to alter biofilm formation or maintenance in B. cenocepacia J2315.
The exact mechanism of this interaction remains unclear, although there exist
several explanative possibilities. First, B. cenocepacia secretion may be altering the pH
of the medium. However, destruction of S. aureus biofilm is not likely occurring due to
decreasing the pH. The CF lung, which S. aureus frequently infects, is acidic in
comparison to a healthy lung due to the improper transport of bicarbonate ions [117].
Additionally, low pH can be an environmental signal to initiate biofilm formation in
staphylococcal species [118]. Its ability to survive in low pH conditions suggests a
different mechanism is causing degradation of S. aureus biofilm. Further, our data
suggests this inhibitory effect may be specific to S. aureus, as similar inhibition was not
observed for P. aeruginosa or S. maltophilia (Supplementary Fig. 1). A generalized
mechanism such as decreased pH would theoretically affect biofilm formation in other
species as well. Absence of this effect insinuates that the substance secreted by B.
cenocepacia J2315 specifically targets S. aureus or a component of the S. aureus biofilm.
Another possible mechanism leading to S. aureus biofilm destruction is through
the destruction of the EPS holding the biofilm together, such as through secretions of
polysaccharide hydrolases, DNases, and/or proteases. This destruction would result in
release of cells from the bacterial matrix and back to planktonic growth. This explanation
is easily testable by removing the liquid from a co-culture biofilm, quantitating
planktonic bacteria, and comparing the viable cell count to the CFU/mL of the planktonic
culture of S. aureus monoculture biofilm. The presence of a greater viable cell count of
planktonic S. aureus in co-culture with B. cenocepacia compared to S. aureus in single
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culture would suggest the biofilm matrix is being dissolved and releasing the cells back
into the medium.
Destruction of S. aureus biofilm in such a manner would not be a novel finding. A
serine protease secreted by Staphylococcus epidermidis termed Esp has been shown to
degrade both molecules in the matrix of S. aureus biofilm and molecules essential for
biofilm formation and colonization, such as fibronectin binding proteins [119]. Exposure
to Esp results in degradation of established S. aureus biofilm over time in a similar
manner as exposure to B. cenocepacia and its biofilm supernatant.
Other potential mechanisms to explain the antagonism of secreted compounds to
S. aureus biofilm could be the production of reactive oxygen species (ROS) in the
medium or the production of biofilm-inhibiting lipids. ROS secretion by B. cenocepacia
is less likely, as some Bcc members are killed by certain antibiotics through a resulting
increase in ROS production [120].
Production of biofilm-inhibiting lipids, on the other hand, is a possible
mechanism of S. aureus biofilm reduction. Rhamnolipids produced by P. aeruginosa
have anti-staphylococcal activity [121] and act to decrease biofilm formation in order to
maintain water channels [122]. B. cenocepacia J2315 has been shown to possess the
operon required for rhamnolipid production [123], although the production of
rhamnolipids has not yet been reported in this species. However, the porous biofilm
phenotype shown in our study suggests the importance of water channels in B.
cenocepacia biofilm maturation and maintenance, hinting at a possible role or expression
of the rhamnolipid regulating operon. As a typically aerobic species, access to oxygen is
critical for B. cenocepacia survival. Maintenance of biofilm water channels for access to
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fresh nutrients and oxygen implicate the potential importance of rhamnolipids in B.
cenocepacia virulence, and is therefore a potential mechanism of S. aureus biofilm
inhibition.
In addition to rhamnolipids, B. cenocepacia J2315 produces a lipopeptide capable
of lysing human cells and inhibiting growth of both S. aureus and P. aeruginosa strains
[124]. However, this lipopeptide was only produced at effective concentrations with
vigorous shaking for three days. Our data suggest that the substance secreted by B.
cenocepacia J2315 that inhibits S. aureus biofilm is produced under static conditions for
the same amount of time. It is therefore probable that the inhibition of S. aureus observed
in our data is not occurring through actions of this lipopetide.
Further research into the identity of the B. cenocepacia J2315 secreted substance
could clarify the discrepancy seen in the significant reduction of S. aureus AH1710
biofilm exposed to B. cenocepacia supernatant during CLSM imaging. Co-culture
imaging showed that S. aureus AH1710 was still present in 7-day-old co-culture biofilm
with B. cenocepacia J2315, while B. cenocepacia supernatant in the absence of viable B.
cenocepacia cells resulted in intensified S. aureus AH1710 biofilm reduction.
A possible mechanism explaining this S. aureus biofilm reduction is the secretion
and re-uptake of a toxic or catabolic substance by B. cenocepacia. P. aeruginosa has
been shown to produce siderophores that are toxic to S. aureus and lead to cell lysis as a
way to scavenge iron [125]. Siderophores are secreted to collect iron from the
environment and are then taken back up by the bacteria. A similar mechanism used by B.
cenocepacia may explain the presence of S. aureus biofilm in co-culture with B.
cenocepacia (Fig. 7E and 7F) in the CLSM experiment, whereas the presence of the B.
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cenocepacia biofilm supernatant without B. cenocepacia cells resulted in S. aureus
biofilm destruction (Fig. 9). If B. cenocepacia is secreting a molecule that destroys S.
aureus biofilm but the molecule can be taken back up into the cell, then the presence of
B. cenocepacia could be somewhat ameliorating to S. aureus biofilm degradation in such
a situation. B. cepacia complex isolates have been shown to produce a variety of
siderophores including ornibactin, pyochelin, salicylic acid, and cepabactin [126-129].
There are many hypotheses to be explored and tested as a result of the data
presented in this thesis. Though the exact mechanism underlying the B. cenocepacia
mediated destruction of S. aureus biofilm remains to be elucidated, the degradation of S.
aureus biofilm by a potentially novel substance is an exciting finding. The increasing
prevalence of antibiotic resistance in both MSSA and MRSA necessitates the discovery
of both new antibacterials and targets for therapeutics.
There are antibacterials on the market that can effectively treat S. aureus infection
in CF and other individuals [130], but antibiotic resistance by bacteria protected in
biofilms prevents treatment of the underlying infection. Should further experimentation
reveal that the substance secreted or shed by B. cenocepacia results in dissolution of S.
aureus biofilm matrix, it could implicate a potential therapeutic solution to elimination of
S. aureus biofilms.
Future directions for this research include the identification of the substance of
interest being secreted by B. cenocepacia J2315, use of tissue cultures as a surface for coculture biofilm formation, analysis and comparison of gene expression between B.
cenocepacia planktonic and biofilm lifestyles, as well as continuous capture of CLSM
images to create and observe a time lapse of co-culture biofilm formation and S. aureus
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biofilm degradation. Results from these proposed experiments, used in conjunction with
the findings of this paper, could reveal a novel antimicrobial agent or a new target for S.
aureus biofilm reduction.
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Supplementary Table 1. Description of incubation times and colony
morphology by strain.
Strain
A. xylosoxidans
AU19284

Colony Morphology

Incubation Time

Small colonies, white

48 h

P. aeruginosa C3719

Large colonies, tinged pink

24-48 h

S. maltophilia K279a

Largest colonies, dark
yellow

24h

S. aureus NRS77

Large colonies, white

24 h

B. cenocepacia J2315

Smallest colonies, tan,
produce a brown pigment

At least 48 h
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Supplementary Figure 1. Co-culture biofilm formation of common CF pathogens. Viable
cell counts of A. xylosoxidans AU19284 (A), S. maltophilia K279a (B), and P. aeruginosa C3719
(C) biofilm grown were compared when grown in with A. xylosoxidans (red), P. aeruginosa
C3719 (orange), S. maltophilia K279a (green), S. aureus NRS77 (blue), or B. cenocepacia J2315
(purple). Presence of “X” indicates contamination, and therefore exclusion of data. Absence of a
bar indicates the CFU/mL is below the limit of detection, which was 105 for this experiment.
One-way ANOVA analysis with Tukey’s multiple comparison test was used to determine
significance (*p < 0.05, **p < 0.01).

The ability of S. maltophilia K279a to form biofilm was not affected by the
presence of the tested strains. There was no significant difference in S. maltophilia K279a
biofilm formation in monoculture compared to co-culture conditions on both day one and
day three of biofilm formation. On the other hand, the presence of S. maltophilia K279a
in co-culture reduced biofilm formation below the limit of detection in both A.
xylosoxidans AU19284 and P. aeruginosa C3719. The biofilm formation of A.
xylosoxidans AU19284 in co-culture with B. cenocepacia J2315 was significantly greater
than monoculture on day one, but was significantly lower than monoculture on day three.
Interestingly, the presence of S. aureus NRS77 significantly inhibits A. xylosoxidans
AU19284 biofilm formation on day one, and reduces biofilm below the limit of detection
on day three. P. aeruginosa C3719 biofilm was significantly increased due to the
presence of B. cenocepacia J2315 on day one, but biofilm formation on day three in this
co-culture condition was not statistically significant in comparison to monoculture.
Repeated experimentation over a longer period of time or with a lower limit of detection
would further elucidate the interactions between some of these isolates in co-culture
conditions.
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